Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Rivaroxaban Use in Patients with Hemoglobinopathies.
Hemoglobin. 2017 May;41(3):223-224. doi: 10.1080/03630269.2017.1374969.
Hemoglobin. 2017.
PMID: 28950780
Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
Vlachaki E, Gavriilaki E, Kafantari K, Adamidou D, Tsitsikas D, Chasapopoulou E, Anagnostopoulos A, Tsapas A.
Vlachaki E, et al. Among authors: kafantari k.
Hemoglobin. 2018 Sep-Nov;42(5-6):339-341. doi: 10.1080/03630269.2018.1540353. Epub 2019 Jan 9.
Hemoglobin. 2018.
PMID: 30626228
Item in Clipboard
Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents.
Andreadis P, Kafantari K, Agapidou A, Vakalopoulou S, Vlachaki E.
Andreadis P, et al. Among authors: kafantari k.
Balkan Med J. 2018 Jan 20;35(1):112-115. doi: 10.4274/balkanmedj.2017.0158. Epub 2017 Sep 13.
Balkan Med J. 2018.
PMID: 28903884
Free PMC article.
Item in Clipboard
Cite
Cite